TRVI - Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.01
2023-05-11 16:26:17 ET
- Trevi Therapeutics press release ( NASDAQ: TRVI ): Q1 GAAP EPS of -$0.06 beats by $0.01 .
- The Company ended the first quarter of 2023 with $111.3 million in cash, cash equivalents and marketable securities.
For further details see:
Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.01